{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T19:31:20Z","timestamp":1773343880109,"version":"3.50.1"},"reference-count":58,"publisher":"Informa UK Limited","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Climacteric"],"published-print":{"date-parts":[[2005,6]]},"DOI":"10.1080\/13697130500118027","type":"journal-article","created":{"date-parts":[[2005,9,7]],"date-time":"2005-09-07T01:42:27Z","timestamp":1126057347000},"page":"99-109","source":"Crossref","is-referenced-by-count":20,"title":["Controversial issues in climacteric medicine IV - Postmenopausal osteoporosis: therapeutic options"],"prefix":"10.1080","volume":"8","member":"301","published-online":{"date-parts":[[2009,7,3]]},"reference":[{"key":"CIT0001","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-199614030-00003"},{"key":"CIT0002","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2004.03.028"},{"key":"CIT0003","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsbmb.2004.02.010"},{"key":"CIT0004","first-page":"728","volume":"34","author":"Bagger YZ","year":"2004","journal-title":"Two to three years of hormone replacement treatment in healthy women have long-term preventive effects on bone mass and osteoporotic fractures: the PERF study. Bone"},{"key":"CIT0005","first-page":"847","volume":"287","author":"Barrett-Connor E","year":"2002","journal-title":"al. MORE Investigators (Multiple Outcomes of Raloxifene Evaluation). Raloxifene and cardio-vascular events in osteoporotic postmenopausal women: four-year results from the MORE rando-mized trial. JAMA"},{"key":"CIT0006","first-page":"1207","volume":"349","author":"Black DM","year":"2003","journal-title":"The effects of parathyroid hormone and alendronate alone or in combination in postmenopausal osteoporosis. N Engl J Med"},{"key":"CIT0007","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(96)07088-2"},{"key":"CIT0008","doi-asserted-by":"publisher","DOI":"10.1023\/A:1020076426727"},{"key":"CIT0009","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-003-1476-2"},{"key":"CIT0010","first-page":"1729","volume":"290","author":"Cauley JA","year":"2003","journal-title":"The Women's Health Initiativerandomizedtrial.JAMA"},{"key":"CIT0011","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(93)90218-E"},{"key":"CIT0012","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-5793(01)02160-3"},{"key":"CIT0014","doi-asserted-by":"publisher","DOI":"10.1023\/A:1006478317173"},{"key":"CIT0015","first-page":"1409","volume":"162","author":"Civitelli R","year":"2002","journal-title":"ArchInternMed"},{"key":"CIT0016","first-page":"873","volume":"144","author":"Christiansen MS","year":"1984","journal-title":"Placebo-controlled trial of its gynecologic and metabolic actions. Am J Obstet Gynecol"},{"key":"CIT0017","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(96)70148-8"},{"key":"CIT0018","doi-asserted-by":"publisher","DOI":"10.1001\/jama.280.24.2077"},{"key":"CIT0019","doi-asserted-by":"publisher","DOI":"10.1016\/S0029-7844(98)00270-1"},{"key":"CIT0020","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9378(96)70366-6"},{"key":"CIT0021","doi-asserted-by":"publisher","DOI":"10.1097\/00042192-199906030-00003"},{"issue":"1","key":"CIT0022","first-page":"1169","volume":"19","author":"Deal C","year":"2004","journal-title":"J Bone Min Res"},{"key":"CIT0023","doi-asserted-by":"publisher","DOI":"10.1359\/jbmr.040117"},{"key":"CIT0024","first-page":"3609","volume":"87","author":"Delmas PD","year":"2002","journal-title":"Efficacy of raloxifene on vertebral fracture risk reduction in postmenopausal women with osteo-porosis: four-year results from a randomized clinical trial. J Clin Endocrinol Metab"},{"key":"CIT0025","doi-asserted-by":"publisher","DOI":"10.1016\/S8756-3282(03)00241-2"},{"key":"CIT0026","first-page":"40","volume":"106","author":"Ettinger B","year":"1987","journal-title":"Postmenopausal bone loss is prevented by treatment with low-dosage estrogen with calcium. Ann Intern Med"},{"key":"CIT0027","doi-asserted-by":"publisher","DOI":"10.1016\/S0378-5122(02)00327-4"},{"key":"CIT0028","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2004.07.006"},{"key":"CIT0029","doi-asserted-by":"publisher","DOI":"10.1016\/S0029-7844(01)01390-4"},{"key":"CIT0031","first-page":"1344","volume":"282","author":"Harris ST","year":"1999","journal-title":"Ver-tebral Efficacy with Risedronate Therapy (VERT) Study Group. JAMA"},{"issue":"1","key":"CIT0032","first-page":"1215","volume":"19","author":"Harris ST","year":"2004","journal-title":"J Bone Min Res"},{"key":"CIT0033","doi-asserted-by":"publisher","DOI":"10.1359\/JBMR.040306"},{"key":"CIT0035","doi-asserted-by":"publisher","DOI":"10.1126\/science.1070442"},{"key":"CIT0036","first-page":"1262","volume":"15","author":"Kian Tee M","year":"2004","journal-title":"Estradiol and selective estrogen receptor modula-tors differentially regulate target genes with estrogen receptors alpha and beta. Mol Biol Cell"},{"key":"CIT0037","doi-asserted-by":"publisher","DOI":"10.1210\/endo.142.9.8402"},{"key":"CIT0038","doi-asserted-by":"publisher","DOI":"10.1001\/jama.287.20.2668"},{"key":"CIT0039","first-page":"759","volume":"63","author":"Lindsay R","year":"1984","journal-title":"The minimum effective dose of estrogen for prevention of postmenopausal bone loss. Obstet Gynecol"},{"key":"CIT0040","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9378(87)90177-3"},{"key":"CIT0041","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(97)02342-8"},{"issue":"1","key":"CIT0042","first-page":"F424","volume":"19","author":"McClung M","year":"2004","journal-title":"J Bone MM Res"},{"key":"CIT0043","first-page":"18","volume":"18","author":"Marcus R","year":"2003","journal-title":"The skeletal response to teriparatide is largely inde-pendent of age, initial bone mineral density, and prevalent vertebral fractures in postmenopausal women with osteoporosis. J Bone Miner Res"},{"key":"CIT0044","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.162.10.1140"},{"key":"CIT0045","first-page":"2060","volume":"87","author":"Meunier PJ","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"CIT0046","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa022436"},{"key":"CIT0047","first-page":"1858","volume":"20","author":"Michaelsson K","year":"1998","journal-title":"The Swedish Hip Fracture Study Group. Br Med J"},{"key":"CIT0048","first-page":"1481","volume":"1","author":"Michaelsson K","year":"1999","journal-title":"Ljunghall S. Oral-contraceptive use and risk of hip fractures: a case-control study. Lancet"},{"key":"CIT0049","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200105103441904"},{"key":"CIT0050","first-page":"785","volume":"285","author":"NIH Consensus Development","year":"2001","journal-title":"Osteoporosis prevention, diagnosis, and therapy. JAMA"},{"key":"CIT0051","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.1989.tb03260.x"},{"key":"CIT0052","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/S0015-0282(16)55848-8","volume":"59","author":"Notelovitz M. Osteoporosis","year":"1993","journal-title":"Fertil Steril"},{"key":"CIT0053","doi-asserted-by":"publisher","DOI":"10.1359\/jbmr.2002.17.2.341"},{"key":"CIT0055","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1200\/JCO.1996.14.1.78","volume":"14","author":"Powles TJ","year":"1996","journal-title":"J Clin Oncol"},{"key":"CIT0056","first-page":"897","volume":"130","author":"Recker RR","year":"1999","journal-title":"Heaney RP. Bone saving effects of low dose continuous estrogen\/progestin with calcium and vitamin D in elderly women: a randomized, controlled trial. Ann Intern Med"},{"key":"CIT0057","doi-asserted-by":"publisher","DOI":"10.1007\/s001980050010"},{"key":"CIT0058","doi-asserted-by":"publisher","DOI":"10.1001\/jama.288.3.321"},{"issue":"1","key":"CIT0060","first-page":"5A428","volume":"19","author":"Sins ES","year":"2004","journal-title":"J Bone MM Res"},{"key":"CIT0061","first-page":"1389","volume":"276","author":"The Writing Group for the PEP","year":"1996","journal-title":"Trial. Effects of hormone replacement therapy on bone mineral density: results from the postmenopausal estro-gen\/progestin interventions (PEP!) trial. JAMA"},{"key":"CIT0062","first-page":"2891","volume":"285","author":"Torgerson DJ","year":"2001","journal-title":"A meta-analysis of randomized trials. JAMA"},{"key":"CIT0063","first-page":"7","volume":"2","author":"Torgerson DJ","year":"2001","journal-title":"A meta-analysis of randomized trials. BMC Muscu-loskeletal Disord"}],"container-title":["Climacteric"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/13697130500118027","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,16]],"date-time":"2017-06-16T23:09:57Z","timestamp":1497654597000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.tandfonline.com\/doi\/full\/10.1080\/13697130500118027"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,6]]},"references-count":58,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2009,7,3]]},"published-print":{"date-parts":[[2005,6]]}},"alternative-id":["10.1080\/13697130500118027"],"URL":"https:\/\/doi.org\/10.1080\/13697130500118027","relation":{},"ISSN":["1369-7137","1473-0804"],"issn-type":[{"value":"1369-7137","type":"print"},{"value":"1473-0804","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,6]]}}}